Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/233250 stock hub

XKON/233250 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/233250is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.7B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/233250

In the news

Latest news · XKON/233250

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-8.2

P25 n/aP50 n/aP75 n/a

ROIC6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/233250 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

KRW

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 15.7B
Price	KRW 8,990
Price currency	KRW
Sic	2835
Symbol	xkon/233250
Website	https://www.mediandiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.61%
FCF yield	-9%
P/B ratio	2.55x
P/S ratio	2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.86%
EBITDA Margin	20.25%
Gross margin	63.01%
Gross Profit	KRW 5B
Net Income	KRW -567.6M
Pretax Margin	-14.93%
Profit Margin	-7.22%
ROA	4.7
ROCE	8.62
ROE	-8.16
ROIC	6.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.93%
Cagr3y	-25.79%
Cagr5y	-25.44%
Revenue Growth	40.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.51
Assets	KRW 15.1B
Cash	KRW 3.7B
Current Assets	KRW 6.7B
Current Liabilities	KRW 1.5B
Debt	KRW 4.3B
Debt EBITDA	KRW 2.72
Debt Equity	KRW 0.7
Debt FCF	KRW -3.07
Equity	KRW 6.2B
Interest Coverage	2.99
Liabilities	KRW 8.9B
Long Term Assets	KRW 8.4B
Long Term Liabilities	KRW 7.4B
Net Cash	KRW -672M
Net Cash By Market Cap	KRW -4.28
Net Debt EBITDA	KRW 0.42
Net Debt Equity	KRW 0.11
Tangible Book Value	KRW 5.8B
Tangible Book Value Per Share	KRW 5,032
WACC	5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.31
Inventory Turnover	2.63
Net Working Capital	KRW 2.3B
Quick ratio	3.2
Working Capital	KRW 5.1B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.91%
200-day SMA	11,372.4
3Y total return	-59.14%
50-day SMA	9,470.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-76.95%
All Time High	63,000
All Time High Change	-85.73%
All Time High Date	2021-03-19
All Time Low	7,740
All Time Low Change	16.15%
All Time Low Date	2026-04-02
ATR	332.8
Beta	0.12
Beta1y	0.35
Beta2y	0.35
Ch YTD	-21.69
High52	15,990
High52 Date	2025-05-15
High52ch	-43.78%
Low52	7,740
Low52 Date	2026-04-02
Low52ch	16.15%
Ma50ch	-5.07%
Price vs 200-day SMA	-20.95%
RSI	47.1
RSI Monthly	28.19
RSI Weekly	37.48
Sharpe ratio	-0.47x
Sortino ratio	-0.57
Tr YTD	-21.69
Tr1m	9.63%
Tr1w	-0.11%
Tr3m	-12.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 1.2B
Operating margin	14.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	259,012%
Net Borrowing	-2,050,000,000
Shares Insiders	1.18%
Shares Out	1,746,534

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -1.4B
Average Volume	42x
Bv Per Share	5,378.5
CAPEX	KRW -1.4B
Ch1m	9.63
Ch1w	-0.11
Ch1y	-37.91
Ch3m	-12.72
Ch3y	-59.14
Ch5y	-76.95
Ch6m	-25.02
Change	-0.11%
Close	9,000
Depreciation Amortization	424,181,000
EBIT	KRW 1.2B
EBITDA	KRW 1.6B
EPS	KRW -496
F Score	2
FCF	KRW -1.4B
FCF Per Share	KRW -809
Financing CF	-3,079,600,000
Fiscal Year End	December
Founded	1,999
Income Tax	KRW -605.7M
Investing CF	-2,361,281,040
Is Primary Listing	1
Ma150	10,919.1
Ma150ch	-17.67%
Ma20	8,980.5
Ma20ch	0.11%
Net CF	-5,443,199,560
Ppne	7,092,076,350
Price Date	2026-05-07
Price EBITDA	KRW 9.86
Ptbv Ratio	2.73
Relative Volume	0.59x
Revenue	7,861,062,030x
Tax By Revenue	-7.7x
Tr6m	-25.02%
Z Score	1.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/233250 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/233250 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/233250?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/233250 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

-20.9%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

-0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/233250

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/233250 stock rating?

xkon/233250 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/233250 analysis?

The full report lives at /stocks/xkon/233250/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/233250?

The latest report frames xkon/233250 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/233250 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.